United Therapeutics Corp (BSP:U2TH34)
R$ 131 (0%) Market Cap: 111.21 Bil Enterprise Value: 100.22 Bil PE Ratio: 19.07 PB Ratio: 3.69 GF Score: 26/100

Q2 2026 United Therapeutics Corp Earnings Call Transcript

Aug 5, 2026 / 01:00 PM GMT


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

UTHR.OQ - United Therapeutics Corporation
Q2 2026 United Therapeutics Corp Earnings Call
Aug 05, 2026 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
To the United Therapeutics Corporation second quarter 2020.

My name is JL and I'll be a conference operator today.

All participants on the call portion of this webcast will be in a listen-only mode until the question-and-answer portion of the earnings call.

If you'd like to ask a question again during this time, simply pressar, then the number one on your telephone keypad.

If you'd like to withdraw your questions, you could press star 1 again.

Please note that this call is being recorded.

I now turn the webcast over to Harry Silvers investor relations at United Therapeutics.

Thank you, JL, good morning everyone.

It is my pleasure to welcome
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot